AstraZeneca and Oxford said Monday their vaccine was as much as 90% effective in preventing COVID-19, marking the latest candidate to inch closer toward approval.
In reporting that it's coronavirus vaccine reached up to 90% efficacy in clinical trials, AstraZeneca and Oxford University also noted that the jab was more effective when given in a half-dose regimen as opposed to a full.
President Trump said Friday that the U.S. was "way ahead on vaccines" days after Pfizer and partner BioNTech SE announced clinical trial data showed their coronavirus vaccine was 95% effective with no serious side effects for any of the trial patients.
As college students prepare to go home for the holidays, some schools are quickly ramping up COVID-19 testing to try to keep infections from spreading further as the coronavirus surges across the U.S.
The U.S. Food and Drug Administration (FDA) on Thursday issued emergency approval to a drug combo to treat moderate to seriously ill, hospitalized coronavirus patients.
The World Health Organization (WHO) has advised against using Gilead’s remdesivir in patients hospitalized with coronavirus, weeks after the drug was shown to have “little or no effect” during the agency’s multicountry Solidarity Trial.
Coronavirus vaccines could begin arriving in Pennsylvania as soon as next month – but don’t put your mask away anytime soon, the state’s top health official said Thursday, according to a report.